NATIONAL

- Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), INSERM U1048, Toulouse

- INSERM U1034, Bordeaux

- INSERM U1011 et LIRIC UMR995, Lille

- EA 3801 "Hémostase et remodelage vasculaire post-ischémie (HERVI)", Reims

- Groupe Hospitalier Pitié Salpêtrière, Paris

- Unité EGEAL, Institut LaSalle, Beauvais

- Hôpital Ambroise Paré, Boulogne-Billancourt

- CHU Angers, Angers

- Centre de Recherche des Cordeliers, Paris

INTERNATIONAL

- Institute of Pharmacy, Biosciences, Martin Luther University Halle-Wittenberg, Halle, Germany

- University of Basilicata, Potenza, Italy

- New York University School of Medicine, New York, USA

- M.M. Shemyakin &Yu.A. Ovchinnikov, Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia

- Faculty of Biology Medicine and Health, University of Manchester, Manchester , UK

- Faculty of Pharmaceutical Sciences, K.U. Leuven, Belgium

- Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium

- Institute for Neuropathology, University of Freiburg, Freiburg, Germany

- Heidelberg University, Heidelberg, Germany

INDUSTRIAL

- Société Soliance, Pomacle-Bazancourt

- Laboratoires Pierre Fabre, Toulouse